Showing results (141-150 of 3,911) with videos related to

Sort By:
Pageof 392
Stem Cell Research|February 18, 2021
Medical progress: Stem cells as a new therapeutic strategy for COVID-19Claudia Musial, Magdalena Gorska-Ponikowska
Stem Cell Research|February 19, 2021
Generation of human induced pluripotent stem cell line FDCHDPi001-A from a Chinese Han Tourette's syndrome patientAihua Yuan, Ran Tao, Shunying Yu, et al.
Stem Cell Research|February 19, 2021
Establishment of a CRISPR/Cas9-mediated ANP32A homozygous knockout human embryonic stem cell lineCong Zhang, Yanxing Wei, Yanqi Zhang, et al.
Stem Cell Research|February 25, 2021
Derivation of four iPSC lines from a male ASD patient carrying a deletion in the middle coding region of NRXN1α gene (NUIGi039-A and NUIGi039-B) and a male sibling control (NUIGi040-A and NUIGi040-B)Yicheng Ding, Aisling O'Brien, Berta Marcó de la Cruz, et al.
Stem Cell Research|February 8, 2021
Establishment of an induced pluripotent stem cell line (SAHGMUi001-A) from a patient with Netherton syndrome carrying SPINK5 mutationMin Xu, Liang Wang, Jiawen Yin, et al.
Stem Cell Research|February 6, 2021
Establishment and characterization of induced pluripotent stem cell (iPSCs) line UNIBSi014-A from a healthy female donorFederica Bono, Veronica Mutti, Giovanna Piovani, et al.
Stem Cell Research|February 6, 2021
Generation of six human induced pluripotent stem cell sublines (MZT01E, MZT01F, MZT01N and MZT02D, MZT02G and MZT02H) for reproductive science researchErica C Pandolfi, Enrique Sosa, Timothy J Hunt, et al.
Stem Cell Research|February 12, 2021
Generation of two iPSC clones (MHHi021-A and MHHi021-B) from a patient with hypertrophic cardiomyopathy with p.Arg723Gly mutation in the MYH7 geneS Merkert, S Wunderlich, J Beier, et al.
Stem Cell Research|February 25, 2017
Modeling Glanzmann thrombasthenia using patient specific iPSCs and restoring platelet aggregation function by CD41 overexpressionLiang Hu, Lili Du, Yan Zhao, et al.
Stem Cell Research|February 8, 2017
Ex vivo expansion of CD3depleted cord blood-MNCs in the presence of bone marrow stromal cells; an appropriate strategy to provide functional NK cells applicable for cellular therapyEhteramolsadat Hosseini, Mehran Ghasemzadeh, Maedeh Kamalizad, et al.
Pageof 392